Developing Recommendations to Guide Future Evidence Generation, Evidence Synthesis, and Knowledge Translation for Rare Diseases
Introduction: The scarcity of rigorous evidence regarding rare disease therapies contributes to uncertainty for stakeholders who make decisions about the use, prescription, or funding of such therapies. My dissertation objective was to integrate stakeholder perspectives and evidence related to how r...
Main Author: | |
---|---|
Other Authors: | |
Format: | Others |
Language: | en |
Published: |
Université d'Ottawa / University of Ottawa
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/10393/42030 http://dx.doi.org/10.20381/ruor-26252 |